Reaves W H & Co. Inc. Sells 2,395 Shares of Exelon Co. (NASDAQ:EXC)

Reaves W H & Co. Inc. lessened its holdings in Exelon Co. (NASDAQ:EXC) by 11.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 17,840 shares of the company’s stock after selling 2,395 shares during the quarter. Reaves W H & Co. Inc.’s holdings in Exelon were worth $671,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Stephens Consulting LLC grew its holdings in Exelon by 78.1% during the fourth quarter. Stephens Consulting LLC now owns 782 shares of the company’s stock valued at $29,000 after purchasing an additional 343 shares during the period. Brown Lisle Cummings Inc. acquired a new position in Exelon during the fourth quarter valued at approximately $30,000. Ashton Thomas Securities LLC acquired a new position in Exelon during the third quarter valued at approximately $32,000. Crews Bank & Trust acquired a new position in Exelon during the fourth quarter valued at approximately $34,000. Finally, Capital Advisors Ltd. LLC grew its holdings in Exelon by 119.6% during the fourth quarter. Capital Advisors Ltd. LLC now owns 942 shares of the company’s stock valued at $35,000 after purchasing an additional 513 shares during the period. Institutional investors own 80.92% of the company’s stock.

Exelon Stock Performance

Shares of EXC stock opened at $44.55 on Tuesday. The company’s fifty day simple moving average is $40.28 and its 200-day simple moving average is $39.40. The company has a quick ratio of 0.78, a current ratio of 0.87 and a debt-to-equity ratio of 1.61. The firm has a market cap of $44.78 billion, a PE ratio of 18.18, a P/E/G ratio of 2.86 and a beta of 0.56. Exelon Co. has a 12 month low of $34.01 and a 12 month high of $44.62.

Exelon (NASDAQ:EXC) last announced its quarterly earnings data on Wednesday, February 12th. The company reported $0.64 EPS for the quarter, topping analysts’ consensus estimates of $0.59 by $0.05. Exelon had a net margin of 10.68% and a return on equity of 9.52%. During the same period last year, the firm earned $0.60 EPS. Equities research analysts expect that Exelon Co. will post 2.64 EPS for the current fiscal year.

Exelon Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, March 14th. Shareholders of record on Monday, February 24th will be given a dividend of $0.40 per share. This is a positive change from Exelon’s previous quarterly dividend of $0.38. This represents a $1.60 annualized dividend and a yield of 3.59%. The ex-dividend date of this dividend is Monday, February 24th. Exelon’s dividend payout ratio is 65.31%.

Insiders Place Their Bets

In other Exelon news, EVP Colette D. Honorable sold 1,463 shares of the company’s stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $40.57, for a total transaction of $59,353.91. Following the sale, the executive vice president now directly owns 2,271 shares of the company’s stock, valued at approximately $92,134.47. This represents a 39.18 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 0.10% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have weighed in on EXC shares. Evercore ISI raised shares of Exelon from an “in-line” rating to an “outperform” rating and lifted their price target for the company from $43.00 to $44.00 in a research note on Tuesday, January 21st. BMO Capital Markets reaffirmed an “outperform” rating on shares of Exelon in a research note on Tuesday, February 4th. Barclays lifted their price target on shares of Exelon from $42.00 to $48.00 and gave the company an “overweight” rating in a research note on Tuesday, February 25th. Morgan Stanley cut their price target on shares of Exelon from $46.00 to $44.00 and set an “equal weight” rating on the stock in a research note on Friday, November 22nd. Finally, Guggenheim raised shares of Exelon from a “neutral” rating to a “buy” rating in a research note on Thursday, January 23rd. Five research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $44.13.

About Exelon

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.